Published in Lancet on February 03, 2001
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study. Lancet (2011) 4.23
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet (2010) 4.23
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol (2005) 3.17
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
Evaluation of new treatments in radiation oncology: are they better than standard treatments? JAMA (2005) 2.37
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care (2010) 1.97
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials (2011) 1.49
Interventions employing mobile technology for overweight and obesity: an early systematic review of randomized controlled trials. Obes Rev (2012) 1.45
The case for randomized controlled trials to assess the impact of clinical information systems. J Am Med Inform Assoc (2011) 1.42
Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care. Psychol Sci Public Interest (2008) 1.34
The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research. Cancer Control (2009) 1.04
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS One (2013) 1.03
Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients? Crit Care (2008) 1.00
Bench-to-bedside review: the evaluation of complex interventions in critical care. Crit Care (2008) 1.00
Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Med (2012) 0.99
Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis (2007) 0.96
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail (2014) 0.93
Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial. Int J Stroke (2014) 0.88
How to spot bias and other potential problems in randomised controlled trials. J Neurol Neurosurg Psychiatry (2004) 0.87
When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt. BMC Med Res Methodol (2012) 0.86
Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study. PLoS One (2015) 0.83
Demography and health of Pugs under primary veterinary care in England. Canine Genet Epidemiol (2016) 0.83
Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds. Circulation (2016) 0.82
Anticoagulant therapy for patients with ischaemic stroke. Nat Rev Neurol (2012) 0.82
Do health economic evaluations using observational data provide reliable assessment of treatment effects? Health Econ Rev (2013) 0.82
Study design issues in evaluating immune biomarkers. Curr Opin HIV AIDS (2013) 0.80
The contribution of observational studies to the knowledge of drug effectiveness in heart failure. Br J Clin Pharmacol (2007) 0.79
Evaluating treatment effects reliably. BMJ (2002) 0.79
Individual and composite study endpoints: separating the wheat from the chaff. Am J Med (2014) 0.78
Enhancing clinical evidence by proactively building quality into clinical trials. Clin Trials (2016) 0.78
Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial. Int J Stroke (2014) 0.77
Large multicenter trials: what do they achieve and what should be done in perfusion? J Extra Corpor Technol (2007) 0.77
Clinical endpoints in trials of drugs for cancer: time for a rethink? BMJ (2002) 0.76
Ethical and scientific considerations for patient enrollment into concurrent clinical trials. Trials (2014) 0.76
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy. Am Heart J (2016) 0.76
Randomized controlled trials - a matter of design. Neuropsychiatr Dis Treat (2016) 0.75
Solving the challenges of large multicenter trials in anesthesia. HSR Proc Intensive Care Cardiovasc Anesth (2009) 0.75
What's new in trial design: propensity scores, equivalence, and non-inferiority. J Extra Corpor Technol (2009) 0.75
A social network analysis of treatment discoveries in cancer. PLoS One (2011) 0.75
The burden of proof: The current state of atrial fibrillation prevention and treatment trials. Heart Rhythm (2017) 0.75
Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND). Trials (2016) 0.75
Reduction of postoperative mortality and morbidity. Little information was given on inclusion criteria. BMJ (2001) 0.75
Clinical trials are too often founded on poor quality pre-clinical research. J Neurol (2005) 0.75
Safety of carotid stenting for stroke prevention: need of an independent outcome assessor. Neurol Sci (2009) 0.75
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45
Management of raised blood pressure in New Zealand: a discussion document. BMJ (1993) 3.96
Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (1994) 3.09
Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ (1996) 2.90
Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet (1988) 2.84
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52
Pravastatin therapy and the risk of stroke. N Engl J Med (2000) 2.46
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J (2008) 2.41
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care (2003) 2.36
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. J Hypertens (2007) 2.01
Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Am Coll Cardiol (1997) 1.79
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost (2007) 1.69
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke (2003) 1.60
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet (2000) 1.56
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol (2001) 1.54
Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. J Card Fail (1998) 1.45
Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J (1997) 1.45
Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study. Eur Heart J (1994) 1.38
Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ (1996) 1.36
Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders. Tob Control (1998) 1.31
Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol (2001) 1.29
APOE genotype, ethnicity, and the risk of cerebral hemorrhage. Neurology (2008) 1.24
Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl (2000) 1.21
Alcohol consumption and hypertension. Hypertension (1987) 1.21
Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation (1995) 1.21
Obesity and hypertension: epidemiological and clinical issues. Eur Heart J (1987) 1.20
Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke (1994) 1.18
Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem (1997) 1.15
Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Stroke (2003) 1.11
PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected]. J Hypertens (1995) 1.09
Mortality after hip fracture: regional variations in New Zealand. N Z Med J (1999) 1.04
Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries. J Epidemiol Community Health (2003) 1.04
Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91. N Z Med J (1995) 1.00
The determinants of fat intake in a multi-ethnic New Zealand population. Fletcher Challenge--University of Auckland Heart and Health Study Management Committee. Int J Epidemiol (1998) 0.98
Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost (1995) 0.95
Chronic suppurative osteomyelitis of the mandible: case report. Aust Dent J (2005) 0.95
Socioeconomic distribution of smoking in a population of 10,529 New Zealanders. N Z Med J (1997) 0.93
Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed) (1987) 0.93
Left ventricular mass correlates with fat-free mass but not fat mass in adults. J Hypertens (1999) 0.92
Blood pressure and the global burden of cardiovascular disease. Clin Exp Hypertens (1999) 0.91
Regional variation in the incidence of hip fracture in New Zealand. N Z Med J (1997) 0.89
Prevention of cardiovascular diseases in developing countries: agenda for action (statement from a WHO-ISH Meeting in Beijing, October 1999). J Hypertens (2000) 0.86
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group. Br J Ophthalmol (1995) 0.86
Beta-blockers in heart failure: promising or proved? J Am Coll Cardiol (1994) 0.85
Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis. PERFECT Study Collaborative Group. Nephrol Dial Transplant (1997) 0.84
Blood pressure and the risk of cardiovascular disease. N Engl J Med (2000) 0.84
The Cochrane Collaboration: New Zealand gets involved. N Z Med J (1996) 0.84
Motor vehicle driver injury and marital status: a cohort study with prospective and retrospective driver injuries. Inj Prev (2004) 0.82
Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial. Kidney Int (2008) 0.81
Blood pressure lowering for the secondary prevention of myocardial infarction and stroke. Hypertension (1997) 0.81
Ethnic differences in blood pressure: findings from the Fletcher Challenge-Auckland University Heart and Health Study. N Z Med J (1996) 0.81
Forty years of randomised trials in the New Zealand Medical Journal. N Z Med J (1996) 0.81
B-mode ultrasound images of the carotid artery wall: correlation of ultrasound with histological measurements. Atherosclerosis (1993) 0.81
Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons. Aust N Z J Surg (1994) 0.80
Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) pilot phase. Clin Exp Pharmacol Physiol (1996) 0.79
Selection bias in clinical research when subjects are excluded because of failure to estimate left ventricular mass by echocardiography. J Am Soc Echocardiogr (1998) 0.79
Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. J Card Fail (2000) 0.79
Blood pressure and coronary heart disease. Lancet (1990) 0.79
The World Health Organization--International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration: prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments. Curr Hypertens Rep (1999) 0.79
An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. Clin Exp Hypertens (1999) 0.78
Migraine: a risk factor for motor vehicle driver injury? Accid Anal Prev (1997) 0.78
Attitudes and practices of New Zealand anaesthetists with regard to epidural and subarachnoid anaesthesia. Anaesth Intensive Care (1996) 0.78
Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration. Am J Hypertens (1999) 0.78
PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. J Hypertens Suppl (2000) 0.77
Blood pressure lowering in diabetes: a brief review of the current evidence and description of a new trial. Clin Exp Pharmacol Physiol (2001) 0.76
Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. Eur Heart J (2003) 0.76
A direct threat to research in public hospitals. N Z Med J (1995) 0.75
Management of raised blood pressure. N Z Med J (1994) 0.75
Hormone replacement therapy. N Z Med J (1994) 0.75
Antiplatelet therapy and the prevention of thrombosis. Aust N Z J Med (1996) 0.75
Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group. J Nephrol (1997) 0.75
Combating the new epidemics of chronic diseases and injuries in the Asia-Pacific region. Med J Aust (2000) 0.75
Treatment for high blood pressure: evidence and practice. Evid Based Cardiovasc Med (1998) 0.75
The associations of diastolic blood pressure with the risk of stroke in Western and Eastern populations. Clin Exp Hypertens (1999) 0.75
Atherosclerosis and left ventricular hypertrophy: persisting problems in treated hypertensive patients. J Hypertens (1998) 0.75
Pregnancy and leg ulceration. J Wound Care (2004) 0.75
Blood pressure lowering for the prevention of cognitive decline in patients with cerebrovascular disease. PROGRESS Management Committee. Perindopril Protection Against Recurrent Stroke Study. Clin Exp Hypertens (1997) 0.75
Outpatient anesthesia for pediatric ophthalmology. Anesth Analg (1973) 0.75
Patient preference for ketamine: a case report of multiple anesthesias. Anesth Analg (1975) 0.75
Monitoring clinical trials. N Z Med J (1998) 0.75